Profhilo: what it is, who it suits, and how it differs from filler

Profhilo is one of the most searched treatment names in UK aesthetics, which means patients often arrive at consultation having half-decided they want it before you have assessed whether it is right for them. This guide gives you the clear, accurate explanation to use in that conversation: what Profhilo actually is, the standard protocol, who it genuinely suits, and where it sits against filler, skin boosters and polynucleotides. It also covers the consultation and record-keeping detail that protects you on the practitioner side.

What Profhilo is

Profhilo is an injectable hyaluronic acid product described as a bio-remodelling treatment. It contains a high concentration of hyaluronic acid that is thermally stabilised rather than chemically cross-linked in the way dermal fillers are, which gives it a runny, spreadable consistency. Rather than holding its shape at the injection point, it disperses through the tissue, hydrating the skin and supporting improvements in elasticity and firmness over the weeks after treatment.

The patient-friendly summary: Profhilo treats skin quality, not shape. It is aimed at laxity, crepiness and dull, dehydrated skin, most commonly on the lower face, and also used on the neck, hands and other body areas. It does not add volume, lift a feature or fill a line, and patients should not expect a visible structural change.

The BAP technique and the standard protocol

Profhilo is delivered using the BAP (bio-aesthetic points) technique: five anatomically defined injection points on each side of the face, chosen to allow the product to spread while avoiding key vessels and nerves. Each point receives a small bolus, leaving a visible bump that disperses over the following hours.

The standard protocol is two sessions, four weeks apart, with the result assessed around four weeks after the second session. Maintenance sessions are then typically offered every six months or so, adjusted to the individual. The two-session structure is not optional padding: the protocol is designed as a pair, and a patient who has one session and stops has had an incomplete treatment. Make that explicit at consultation and book both sessions at the outset. Treatment areas beyond the face have their own injection-point protocols, so check the manufacturer’s guidance for the specific product and area you are treating.

Profhilo vs filler

This is the comparison patients ask for most, and the distinction is clean.

Dermal filler is a structural product. It is cross-linked so it holds its shape, it is placed where volume or definition is wanted, and the result is visible immediately: a restored cheek, a sharper jawline, a filled fold. Filler answers the question “I want this area to look fuller or more defined”.

Profhilo is a conditioning product. It spreads rather than holds, and it changes how the skin behaves (hydration, elasticity, firmness) rather than how a feature is shaped. The result appears gradually over the weeks after the second session, and it answers the question “I want my skin to look healthier and less lax”.

The two are complementary rather than competing, and many treatment plans use both: Profhilo to improve the canvas, filler for structure where it is needed. The consultation risk runs in both directions, a volume patient who is sold Profhilo will see no result they recognise, and a skin-quality patient pushed toward filler can end up volumised without the skin improvement they actually wanted.

Profhilo vs skin boosters and polynucleotides

Within the skin-quality category, Profhilo sits alongside two neighbours. Traditional skin boosters are softer hyaluronic acid preparations placed as many small superficial injections, primarily delivering hydration; they typically need a course of several sessions and suit fine crepiness and dullness. Polynucleotides are purified DNA-fragment injectables aimed at regeneration, stimulating the skin’s own repair processes over a course of two to three sessions, and are often favoured for the under-eye area and thin, damaged skin.

Profhilo’s distinguishing features are the sparse ten-point facial technique, the fixed two-session protocol and the dual hydration-plus-laxity positioning. In practice many clinics carry all three and choose by area, skin quality and patient preference. If you are building out the category, our skin boosters guide covers it as a whole.

Who it suits

Good candidates are patients in roughly their thirties onwards with early to moderate skin laxity, dehydrated or dull skin, and realistic expectations about a gradual, natural-looking change. It suits patients who want improvement without alteration, and it is often the right first injectable for a filler-hesitant patient. It is less suitable where the real concern is volume loss, deep static lines or significant jowling, where it can be part of a plan but will not carry the result alone. Standard exclusions apply: pregnancy and breastfeeding, active skin infection in the area, and known hypersensitivity to the product’s components.

Consultation and record-keeping

Set expectations precisely: two sessions, four weeks apart, judged a month after the second, with a natural rather than dramatic endpoint. Photograph the patient before the first session in consistent lighting, because gradual skin-quality changes are exactly the kind of result patients forget, and the before-and-after is what anchors the review conversation.

Document each session fully: written consent, product batch number and expiry, injection points used, volume per point and total dose, plus a record that written aftercare was sent. Batch-level records are what make a product recall manageable and are part of the baseline England’s planned licensing scheme is expected to formalise; our licensing-ready records checklist covers the full standard. A signed skin booster consent form adapted to Profhilo, with the BAP points and two-session protocol named, covers the consent side, and our Profhilo aftercare sheet is ready to send after each session. More clinic guides live in the guides library.

Running the two-session protocol without the gaps

The protocol’s weak point in practice is the second session: patients drift, the four-week window slips, and the result suffers. AesthetiClinic books the pair together, chases the second appointment automatically, e-signs the consent before the patient arrives and files the batch number on every record. See the features page for how it fits your clinic.